Abstract
The advancement of anti-cancer treatment has increased survival rates among patients, yet putting them in an increased risk for developing side-effects. In addition to early side-effects, anti-cancer treatments, in particular chemotherapeutic medications can cause long-term side-effects; fertility and sexual dysfunction included. The aim of this study was to review existing data on the effects of different chemotherapeutic agents on fertility and sexual function of male cancer survivors who received chemotherapy at different stages of life. We searched PubMed/MEDLINE, Scopus, and Google Scholar to detect studies focused on the effect of chemotherapy on the gonadal/testicular function and sexual function of male cancer survivors. We restricted our search to English language publications and manuscript published before the year 2000 were excluded. It has been well understood that chemotherapy impairs gonadal function in major number of cancer survivors and gonadal dysfunction is not protected if chemotherapeutic agents administered before puberty in males. Moreover, effect of chemotherapy on sexual function is controversial. While several articles reported the worst effect of chemotherapy on sexual function of cancer survivors, some studied reported that chemotherapy do not impair sexual function. Higher levels of chemotherapy dose seem to be associated with more gonadal and sexual dysfunction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
